does uhc cover glp-1 United Healthcare Zepbound? GLP-1 Weight-Loss Drug Demonstration Begins
Description
Results Disclaimer: Individual results may vary
GLP-1 receptor agonists, including semaglutide, have been observed to reduce food intake, appetite, and hunger while concurrently stimulating feelings of fullness and satiety
A December 2024 poll ( n = 2161) found that 22% of UK adults would use a GLP-1 weight-loss drug if it were available on prescription through the NHS [19], although many of these may not be eligible according to NICE guidelines
However, their FDA approvals differ significantly
